Your session is about to expire
We'll log you out in 60 seconds unless you choose to continue
Continue
Vanderbilt Medical Center Clinical Trials 2022
3 Active Clinical Trials
Closest Location:
Vanderbilt Medical Center
· Nashville, TN
Trials at this site
PT2385 for Kidney Cancer
18+
All Sexes
Nashville, TN
This trial is testing a new drug, MK-3795, for patients with advanced kidney cancer. The goal is to find the maximum tolerated dose (MTD) of the drug for future trials.
Phase 1
Waitlist Available
FDA Approved Drug
Learn More
Vanderbilt Medical Center
Medical Director
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Belzutifan for Kidney Cancer
18+
All Sexes
Nashville, TN
This trial will test if belzutifan can shrink tumors in people with von Hippel-Lindau disease-related kidney cancer.
Phase 2
Waitlist Available
Has No Placebo
Learn More
Vanderbilt Medical Center
Medical Director
Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
INCA 0186 Combination Therapy for Cancer
18 - 90
All Sexes
Nashville, TN
This trial is testing a new cancer treatment to see if it is safe and works well. They will test it on people with certain types of advanced cancer who have not responded to other treatments.
Phase 1
Waitlist Available
Has No Placebo
Learn More
Vanderbilt Medical Center
Ilona Rybicka, MD
Incyte Corporation
Is this your site?
Every week patients are viewing your profile. Claim your page to easily update information, respond to patients, and more!
Claim Profile
Is this your site?
Every week patients are viewing your profile. Claim your page to easily update information, respond to patients, and more!
Claim This Site